OMOP Concept 724904

SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED

StandardDrugCVX213Vaccine Group
Maps from
87
Descendants
0
Valid from
16 Nov 2020
Valid to
31 Dec 2099
OMOP concepts

Concept Lookup Tool

Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.

Source codes that map to this concept

87 source codes normalize to SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED via the OMOP "Maps to" relationship.

VocabularyCodeNameType
CIEL165616Administration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccineNon-standard
CIEL166187Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine series startedNon-standard
CIEL166379Sinopharm-Wuhan COVID-19 vaccineNon-standard
CIEL166394Intramuscular administration of Sinopharm-Wuhan COVID-19 vaccineNon-standard
CIEL166474CureVac CVnCoV COVID-19 vaccineNon-standard
CIEL166475Intramuscular administration of CureVac CVnCoV COVID-19 vaccineNon-standard
CIEL166476Intramuscular administration of first dose of CureVac CVnCoV COVID-19 vaccineNon-standard
CIEL166477Intramuscular administration of second dose of CureVac CVnCoV COVID-19 vaccineNon-standard
CIEL166958Intramuscular administration of COVIran COVID-19 vaccineNon-standard
CIEL166962Intramuscular administration of Soberana-02 COVID-19 vaccineNon-standard
CIEL166963Cadila Healthcare ZyCov-D COVID-19 vaccineNon-standard
CIEL166964Intramuscular administration of ZyCoV-D COVID-19 vaccineNon-standard
CIEL168678Chinese Academy of Medical Sciences COVID-19 vaccineNon-standard
CIEL168679Sinopharm WIBP COVID-19 vaccineNon-standard
CIEL168680Soberana Plus COVID-19 vaccineNon-standard
CIEL168681COVAX-19 vaccineNon-standard
CIEL168682Razi COV PARS vaccineNon-standard
dm+d42645711000001109Generic Nuvaxovid XBB.1.5 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials 10 doseNon-standard
dm+d42645911000001106Nuvaxovid XBB.1.5 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vialsNon-standard
dm+d42646011000001103Nuvaxovid XBB.1.5 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials (Novavax UK Ltd) 10 dose 2 x 5 dose vialsNon-standard
dm+d42646211000001108Generic Nuvaxovid XBB.1.5 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vialsNon-standard
dm+d43109911000001106Generic Comirnaty JN.1 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials 6 doseNon-standard
dm+d43110911000001102Generic Comirnaty JN.1 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials 60 doseNon-standard
dm+d43111411000001101Comirnaty JN.1 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vialsNon-standard
dm+d43111511000001102Comirnaty JN.1 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials (Pfizer Ltd) 60 dose 10 x 6 dose vialsNon-standard
dm+d43111611000001103Comirnaty JN.1 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials (Pfizer Ltd) 6 doseNon-standard
dm+d43112611000001109Generic Comirnaty JN.1 Children 5-11 years COVID-19 mRNA Vaccine 10micrograms/0.3ml dose dispersion for injection single dose vials 10 doseNon-standard
dm+d43112711000001100Comirnaty JN.1 Children 5-11 years COVID-19 mRNA Vaccine 10micrograms/0.3ml dose dispersion for injection single dose vialsNon-standard
dm+d43112911000001103Comirnaty JN.1 Children 5-11 years COVID-19 mRNA Vaccine 10micrograms/0.3ml dose dispersion for injection single dose vials (Pfizer Ltd) 10 dose 10 x 1 single dose vialsNon-standard
dm+d43113011000001106Generic Comirnaty JN.1 Children 6 months - 4 years COVID-19 mRNA Vaccine 3micrograms/0.3ml dose dispersion for injection multidose vials 3 doseNon-standard
dm+d43113111000001107Generic Comirnaty JN.1 Children 6 months - 4 years COVID-19 mRNA Vaccine 3micrograms/0.3ml dose dispersion for injection multidose vials 30 doseNon-standard
dm+d43113211000001101Comirnaty JN.1 Children 6 months - 4 years COVID-19 mRNA Vaccine 3micrograms/0.3ml dose concentrate for dispersion for injection multidose vialsNon-standard
dm+d43113311000001109Comirnaty JN.1 Children 6 months - 4 years COVID-19 mRNA Vaccine 3micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) 3 doseNon-standard
dm+d43113411000001102Comirnaty JN.1 Children 6 months - 4 years COVID-19 mRNA Vaccine 3micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) 30 dose 10 x 3 dose vialsNon-standard
dm+d43113511000001103Generic Comirnaty JN.1 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vialsNon-standard
dm+d43113611000001104Generic Comirnaty JN.1 Children 5-11 years COVID-19 mRNA Vaccine 10micrograms/0.3ml dose dispersion for injection single dose vialsNon-standard
dm+d43113711000001108Generic Comirnaty JN.1 Children 6 months - 4 years COVID-19 mRNA Vaccine 3micrograms/0.3ml dose dispersion for injection multidose vialsNon-standard
dm+d43468411000001106Generic Comirnaty JN.1 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection pre-filled syringes 10 doseNon-standard
dm+d43471411000001105Comirnaty JN.1 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection pre-filled syringesNon-standard
dm+d43471811000001107Comirnaty JN.1 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection pre-filled syringes (Pfizer Ltd) 10 doseNon-standard
dm+d43726311000001100Generic Comirnaty JN.1 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection pre-filled syringesNon-standard
dm+d44457611000001100Generic Nuvaxovid JN.1 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection vials 1 doseNon-standard
dm+d44458011000001108Nuvaxovid JN.1 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection vialsNon-standard
dm+d44458611000001101Nuvaxovid JN.1 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection vials (Novavax UK Ltd) 1 doseNon-standard
dm+d44493611000001102Generic Nuvaxovid JN.1 COVID-19 Vaccine (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection vialsNon-standard
HCPCSM0201Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patient's home; reported only once per individual home per date of service when such vaccine administration(s) are performed at the patient's homeNon-standard
ICD10PCSXW013S6Introduction of COVID-19 vaccine dose 1 into subcutaneous tissue, percutaneous approach, new technology group 6Non-standard
ICD10PCSXW013T6Introduction of COVID-19 vaccine dose 2 into subcutaneous tissue, percutaneous approach, new technology group 6Non-standard
ICD10PCSXW013U6Introduction of COVID-19 vaccine into subcutaneous tissue, percutaneous approach, new technology group 6Non-standard
ICD10PCSXW013V7Introduction of COVID-19 Vaccine Dose 3 into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7Non-standard
ICD10PCSXW013W7Introduction of COVID-19 Vaccine Booster into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7Non-standard
ICD10PCSXW023S6Introduction of COVID-19 vaccine dose 1 into muscle, percutaneous approach, new technology group 6Non-standard
ICD10PCSXW023T6Introduction of COVID-19 vaccine dose 2 into muscle, percutaneous approach, new technology group 6Non-standard
ICD10PCSXW023U6Introduction of COVID-19 vaccine into muscle, percutaneous approach, new technology group 6Non-standard
ICD10PCSXW023V7Introduction of COVID-19 Vaccine Dose 3 into Muscle, Percutaneous Approach, New Technology Group 7Non-standard
ICD10PCSXW023W7Introduction of COVID-19 Vaccine Booster into Muscle, Percutaneous Approach, New Technology Group 7Non-standard
Read65F0.002019-nCoV (novel coronavirus) vaccinationNon-standard
Read65F0100Admin first dse SARS-CoV-2 vacNon-standard
Read65F0200Admin sec dose SARS-CoV-2 vaccNon-standard
Read65F0600Admin SARS-CoV-2 antigen vaccNon-standard
Read65F0700Imm course immunity SARS-CoV-2Non-standard
Read65F0900Admin third dse SARS-CoV-2 vacNon-standard
Read65F0A00Admin fourth SARS-CoV-2 vacNon-standard
Read65F0B00Admin fifth dse SARS-CoV-2 vacNon-standard
Read8B31H00SARS-CoV-2 immun course startNon-standard
Read8B31J00SARS-CoV-2 prot main cour starNon-standard
SNOMED1119305005SARS-CoV-2 antigen vaccineNon-standard
SNOMED1156257007Administration of SARS-CoV-2 vaccineNon-standard
SNOMED1157024006Inactivated whole SARS-CoV-2 antigen vaccineNon-standard
SNOMED1157196000Administration of inactivated whole SARS-CoV-2 antigen vaccineNon-standard
SNOMED1157197009Administration of second dose of inactivated whole SARS-CoV-2 antigen vaccineNon-standard
SNOMED1162643001SARS-CoV-2 recombinant spike protein antigen vaccineNon-standard
SNOMED1162645008Administration of SARS-CoV-2 recombinant spike protein antigen vaccineNon-standard
SNOMED1162646009Administration of second dose of SARS-CoV-2 recombinant spike protein antigen vaccineNon-standard
SNOMED1179496000Administration of SARS-CoV-2 virus-like particle antigen vaccineNon-standard
SNOMED1179497009Administration of second dose of SARS-CoV-2 virus-like particle antigen vaccineNon-standard
SNOMED1187593009SARS-CoV-2 DNA plasmid encoding spike protein vaccineNon-standard
SNOMED1324671000000103Immunisation course to achieve immunity against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2)Non-standard
SNOMED1324681000000101Administration of first dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccineNon-standard
SNOMED1324691000000104Administration of second dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccineNon-standard
SNOMED1324851000000106SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) immunisation course startedNon-standard
SNOMED1363791000000101Administration of fourth dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccineNon-standard
SNOMED1363831000000108Administration of fifth dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccineNon-standard
SNOMED1363861000000103Administration of third dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccineNon-standard
SNOMED28531000087107COVID-19 vaccineNon-standard
SNOMED30141000087107SARS-CoV-2 virus-like particle antigen vaccineNon-standard
SNOMED840534001Administration of SARS-CoV-2 antigen vaccineNon-standard

Get this concept via the API

Resolve SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.

curl "https://api.omophub.com/v1/concepts/724904?include_relationships=true" \
  -H "Authorization: Bearer $OMOPHUB_API_KEY"
Get your free API key3,000 calls/month free · no credit card